Clinical Trial Update: EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EPOCH-R chemotherapy plus bortezomib for mantle cell lymphoma has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma Mantle-cell
• Mantle Cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• EPOCH-R

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Mantle Cell, Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-07-03